{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:26:27Z","timestamp":1789907187403,"version":"4.0.1"},"reference-count":31,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2023,11,4]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Sympathetic crashing acute pulmonary edema (SCAPE) is a subset of heart failure with a dramatic presentation. The unique physiology of this condition requires a different management strategy from the conventional practice. The trial objective was to compare the efficacy of high-dose and low-dose GTN in patients with SCAPE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was an open-label randomised control trial conducted in a tertiary care teaching hospital in India from 11 November 2021 to 30 November 2022. Consenting participants were randomised to high-dose GTN or conventional low-dose GTN. The primary outcome was symptom resolution at 6 hours and 12 hours. Secondary outcomes included intubation rates, admission rates, length of hospital stay, and any short-term adverse effects of GTN and major adverse cardiac events (MACE) at 30 days.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-four participants were included (26 high-dose GTN, 26 low-dose GTN). At 6\u2009hours, symptom resolution was seen in 17 patients (65.4%) in the 'high-dose' group, compared with 3 (11.5%) in the 'low-dose' group (p&lt;0.001). At 12 hours, 88.5% of patients had a clinical resolution in the 'high-dose' arm versus 19.5% in 'low-dose' arm . The low-dose group had longer median hospital stay (12\u2009hours vs 72\u2009hours), more frequent MACE (3.8% vs 26.9%, p=0.02) and a higher intubation rate (3.8% vs 19.2%, p=0.08). The only short-term adverse effect seen was a headache in both the groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In SCAPE, patients receiving high-dose GTN (&gt;100 mcg\/min) had earlier symptom resolution compared with the conventional \u2018low dose\u2019 GTN without any significant adverse effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>Clinical trial registry of India (CTRI\/2021\/11\/037902).<\/jats:p><\/jats:sec>","DOI":"10.1136\/emermed-2023-213285","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T18:20:39Z","timestamp":1701195639000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["High-dose versus low-dose intravenous nitroglycerine for sympathetic crashing acute pulmonary edema: a randomised controlled trial"],"prefix":"10.1136","volume":"41","author":[{"given":"Naazia","family":"Siddiqua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-0399","authenticated-orcid":false,"given":"Roshan","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3232-9308","authenticated-orcid":false,"given":"Ankit Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4343-8809","authenticated-orcid":false,"given":"Nayer","family":"Jamshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothiswaroop","family":"Bhaskararayuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4611-5458","authenticated-orcid":false,"given":"Praveen","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-9765","authenticated-orcid":false,"given":"Akshay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maroof Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"2025062323250782000_41.2.96.1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4103\/0972-5229.195710","article-title":"Sympathetic crashing acute pulmonary edema","volume":"20","author":"Agrawal","year":"2016","journal-title":"Indian J Crit Care Med"},{"key":"2025062323250782000_41.2.96.2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tjem.2018.01.004","article-title":"Treating acute hypertensive cardiogenic pulmonary edema with high-dose nitroglycerin","volume":"18","author":"Hsieh","year":"2018","journal-title":"Turk J Emerg Med"},{"key":"2025062323250782000_41.2.96.3","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307461"},{"key":"2025062323250782000_41.2.96.4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jemermed.2021.05.011","article-title":"High-dose nitroglycerin bolus for sympathetic crashing acute pulmonary edema: a prospective observational pilot study","volume":"61","author":"Mathew","year":"2021","journal-title":"J Emerg Med"},{"key":"2025062323250782000_41.2.96.5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ajem.2022.10.018","article-title":"High-dose nitroglycerin infusion description of safety and efficacy in sympathetic crashing acute pulmonary edema: the HI-DOSE SCAPE study","volume":"63","author":"Houseman","year":"2023","journal-title":"Am J Emerg Med"},{"key":"2025062323250782000_41.2.96.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00785-3"},{"key":"2025062323250782000_41.2.96.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022021"},{"key":"2025062323250782000_41.2.96.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(87)80242-5"},{"key":"2025062323250782000_41.2.96.9","unstructured":"Kim KH , Kerndt CC , Adnan G , et al . Nitroglycerin. StatPearls Publishing, 2022."},{"key":"2025062323250782000_41.2.96.10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.15420\/cfr.2016:3:3","article-title":"Nitrates as a treatment of acute heart failure","volume":"2","author":"Alzahri","year":"2016","journal-title":"Card Fail Rev"},{"key":"2025062323250782000_41.2.96.11","article-title":"Nitrates for acute heart failure syndromes","volume":"2013","author":"Wakai","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025062323250782000_41.2.96.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005419"},{"key":"2025062323250782000_41.2.96.13","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.annemergmed.2022.05.027","article-title":"Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes: approved by ACEP board of directors, June 23, 2022","volume":"80","year":"2022","journal-title":"Ann Emerg Med"},{"key":"2025062323250782000_41.2.96.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)08417-1"},{"key":"2025062323250782000_41.2.96.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2009.02146.x"},{"key":"2025062323250782000_41.2.96.16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.ajem.2018.05.013","article-title":"Recognition of sympathetic crashing acute pulmonary edema (SCAPE) and use of high-dose nitroglycerin infusion","volume":"36","author":"Paone","year":"2018","journal-title":"Am J Emerg Med"},{"key":"2025062323250782000_41.2.96.17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/JETS.JETS_137_19","article-title":"All India Institute of medical sciences triage protocol (ATP): ATP of a busy emergency Department","volume":"13","author":"Sahu","year":"2020","journal-title":"J Emerg Trauma Shock"},{"key":"2025062323250782000_41.2.96.18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025062323250782000_41.2.96.19","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001063"},{"key":"2025062323250782000_41.2.96.20","doi-asserted-by":"crossref","unstructured":"Zhang X , Zhao C , Zhang H , et al . Dyspnea measurement in acute heart failure: a systematic review and evidence map of randomized controlled trials. Front Med 2021;8. doi:10.3389\/fmed.2021.728772","DOI":"10.3389\/fmed.2021.728772"},{"key":"2025062323250782000_41.2.96.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100171"},{"key":"2025062323250782000_41.2.96.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.10.002"},{"key":"2025062323250782000_41.2.96.23","doi-asserted-by":"publisher","DOI":"10.2307\/2346101"},{"key":"2025062323250782000_41.2.96.24","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.2020.19378","article-title":"Effect of an emergency department care bundle on 30-day hospital discharge and survival among elderly patients with acute heart failure: the ELISABETH randomized clinical trial","volume":"324","author":"Freund","year":"2020","journal-title":"JAMA"},{"key":"2025062323250782000_41.2.96.25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ihj.2019.09.012","article-title":"Prevalence of hypertension among Indian adults: results from the great India blood pressure survey","volume":"71","author":"Ramakrishnan","year":"2019","journal-title":"Indian Heart Journal"},{"key":"2025062323250782000_41.2.96.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015639","article-title":"Changes in hypertension prevalence, awareness, treatment and control rates over 20 years in national capital region of India: results from a repeat cross-sectional study","volume":"7","author":"Roy","year":"2017","journal-title":"BMJ Open"},{"key":"2025062323250782000_41.2.96.27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.10971"},{"key":"2025062323250782000_41.2.96.28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000180464","article-title":"Effects of large doses of furosemide in end-stage chronic renal failure","volume":"14","author":"Vereerstraeten","year":"1975","journal-title":"Nephron"},{"key":"2025062323250782000_41.2.96.29","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000184694.03262.6d"},{"key":"2025062323250782000_41.2.96.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(96)00027-2"},{"key":"2025062323250782000_41.2.96.31","first-page":"84","article-title":"Immune disorders in hemodialysis patients","volume":"9","author":"Sharif","year":"2015","journal-title":"Iran J Kidney Dis"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2023-213285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T06:25:21Z","timestamp":1750746321000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2023-213285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,22]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/emermed-2023-213285"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2023-213285","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]}}}